CN
216-424-6
应用筛选条件
关键词:'216-424-6'
显示 1-22 共 22 条结果 关于 "216-424-6" 范围 技术文档
Quality Control Range Sheet- MAGP-108 and MAGP-208
Control 1 104 – 216 pg/mL SDF-1 Control 1 2364 – 4910 pg/mL
Control 2 435 – 904 pg/mL Control 2 9033 – 18760 pg/mL
Quality Control Range Sheet- HCY-116 and HCY-216
737 pg/mL
IFNγ Control 1 85 – 230 pg/mL IL-1α Control 1 89 – 185 pg/mL
Control 2 424 – 950 pg/mL Control 2 430
Data Sheet - E3406
dilutions by titration.
References
1. Schuyler, S.C., and Pellman, D., Cell, 105, 421-
424 (2001).
2. Ou, Y., and Rattner, J.B., Int. Rev. Cytol., 238,
119-182 (2004).
3.
Product Information Sheet - P6024
1983). pp. 190, 210, 285, 407.
24. ibid., (1983). pp. 134, 144, 180, 190,
216, 222, 230, 252.
25. ibid., (1983). pp. 6, 216, 252, 330.
26. ibid., (1983). pp. 88, 90.
27. Guibert, L. and Iscove, N.
XP725 Antibody Number-Lot Number 071M4826
.3 393 394 395 396 417 418 419 420 441 442 443 444 465 466 467 468
5.4 397 398 399 400 421 422 423 424 445 446 447 448 469 470 471 472
5.5 401 402 403 404 425 426 427
Product Information Sheet - I1149
Protein Modification,
CRC Press, London, 1995, 107.
51. Gurd, F.R.N., Methods Enzymol., 25, 424, 1972.
52. Nishita, T. and Deutsch, H.F., Biochem. Biophys.
Res. Commun., 103, 573, 1981.
Product Information Sheet - I6125
Protein Modification,
CRC Press, London, 1995, 107.
51. Gurd, F.R.N., Methods Enzymol., 25, 424, 1972.
52. Nishita, T. and Deutsch, H.F., Biochem. Biophys.
Res. Commun., 103, 573, 1981.
Principles of Steam-In-Place
50 65 80 100
0.5 20 10 20 32 57 77 126 216 301 513
30 16 30 47 85 116 189 324 451 770
1 20 14 26 41 74 101 165 282 393 672
Brochure-Rethink Western Blotting
Milli-Q® water to final
volume 1000 mL. Do not adjust pH.
mPAGE® 4X LDS Sample Buffer
[Tris-HCl]: 424 mM
[Tris]: 564 mM
[LDS]: 8%, 294 mM
[EDTA]: 2.07 mM
[Glycerol]: 40%, 4.34 M
[Coomassie® Blue G250]:
Research Focus - Volume 2, 2013
disease brain. Correlates with increased BACE1 expression. 250
miR-29a-3p Hu-Cy5 SmartFlare™ Probe SF-424 Downregulated in Alzheimer’s disease brain. Correlates with increased BACE1expression. 250
miR-29b
XP725 Antibody List Lot 129K4831
NP_002736.3,NP_620407.1 , y y y
535 p38 MAPK M0800 5594 MAPK1 P NP_002736.3,NP_620407.1 , n/d y y
424 MAP Kinase (ERK-1) M7927 5595 MAPK3 P NP_001035145.1 y y y
247 ERK5 (Big MAPK-BMK1) E1523 5598 MAPK7
XP725 Antibody List Lot 129K4830
NP_002736.3,NP_620407.1 , y y y
535 p38 MAPK M0800 5594 MAPK1 P NP_002736.3,NP_620407.1 , n/d y y
424 MAP Kinase (ERK-1) M7927 5595 MAPK3 P NP_001035145.1 y y y
247 ERK5 (Big MAPK-BMK1) E1523 5598 MAPK7
XP725 Antibody List Lot 089K4791
NP_002736.3,NP_620407.1 , y y y
535 p38 MAPK M0800 5594 MAPK1 P NP_002736.3,NP_620407.1 , n/d y y
424 MAP Kinase (ERK-1) M7927 5595 MAPK3 P NP_001035145.1 y y y
247 ERK5 (Big MAPK-BMK1) E1523 5598 MAPK7
XP725 Worksheet for Lot Number 071M4826
3 1 5 6 Cytokeratin peptide 19 C6930
423 3 1 5 7 Pan Cytokeratin C2931
424 3 1 5 8 Pan Cytokeratin C2931
425 3 1 6 1 DAPK D2178
426 3 1 6 2 DAPK D2178
DAPK pSer308 D4941427 3 1
Katalog neoLab
. .358
6-2176 to 6-2179 . . . . . . . . .358
6-2201 . . . . . . . . . . . . . . . . .157
6-2210 to 6-2212 . .
List of Antibodies
Diphosphorylated ERK-1&2) M9692 M y y y
423 MAP Kinase, Monophosphorylated Threonine M3557 M y y y
424 MAP Kinase (ERK-1) M7927 P y y y
425 MAP Kinase (ERK1+ERK2) M5670 P y y y
426 MAP Kinase Activated
Halal Certificate
Alcohol Natural W217816 C29012 HC-23SIIR10
423. BUTYL BENZOATE, 98% W515000 A16526 HC-23SI9N54
424. BUTYL BUTYRATE 98%, FCC, FG W218618 B39157 HC-23SI9Y17
425. BUTYL BUTYRATE, NATURAL W218626 C44260
Halal Certificate
Alcohol Natural W217816 C29012 HC-22SIRL31
423. BUTYL BENZOATE, 98% W515000 A16526 HC-22SILZ75
424. BUTYL BUTYRATE 98%, FCC, FG W218618 B39157 HC-22SIC238
425. BUTYL BUTYRATE, NATURAL W218626 C44260
3D BIOPRINTING: Printing a Brighter Future
Jin, H.-J.; Kaplan, D. L. Nature 2003, 424, 1057–1061.
(121) Rockwood, D. N.; Preda, R. C.; Yücel, T.; Wang, X.; Lovett, M. L.; Kaplan,
D. L. Nat. Protoc. 2011, 6, 1612.
(122) Kim, U.-J.; Park, J.; Li
3D BIOPRINTING: Printing a Brighter Future
Jin, H.-J.; Kaplan, D. L. Nature 2003, 424, 1057–1061.
(121) Rockwood, D. N.; Preda, R. C.; Yücel, T.; Wang, X.; Lovett, M. L.; Kaplan,
D. L. Nat. Protoc. 2011, 6, 1612.
(122) Kim, U.-J.; Park, J.; Li
XP725 Antibody List 013M4793
11MAPK3,Mapk1,Mapk3,MAPK1 NP_036079.1,NP_059043.1,NP_620407.1,NP_036082.1,NP_002737.2,NP_4462 M y y y
424 MAP Kinase (ERK-1) M7927 50689, 26417, 5595 MAPK3,Mapk3 NP_059043.1,NP_036082.1,NP_002737.2 P y y y
XP725 Antibody List
5595, 116590 MAPK3,Mapk1,Mapk3,MAPK1 NP_036079.1,NP_059043.1,NP_620407.1,NP_036082.1,NP_00 M y y y
424 MAP Kinase (ERK-1) M7927 50689, 26417, 5595 MAPK3,Mapk3 NP_059043.1,NP_036082.1,NP_002737.2 P y y y